Literature DB >> 22021662

Observations of a small sample of adolescents experiencing an at-risk mental state (ARMS) for psychosis.

Patrick Welsh1, Paul A Tiffin.   

Abstract

Some commentaries express concern that the At-Risk Mental State (ARMS) designation can be stigmatizing and induce a lasting sense of personal fragility. However, no studies have actually explored the personal perspectives of those so categorized. The purpose of this study was to explore how adolescents with an ARMS label understand and experience their condition medically and personally. Six participants receiving an ARMS diagnosis were interviewed and the data analyzed using interpretative phenomenological analysis. Three superordinate themes emerged: "It is better to say it," "How others would take me," and "Just to have somebody to talk to." The participants' experiences of being labeled were generally positive with limited instances of stigmatization by family and friends. Like most psychiatric diagnoses, the ARMS label has the potential to generate stigma. In practice, however, this sample of young people appeared to respect being told about the condition and to value the opportunity of talking about their experiences with mental health professionals and significant others.

Entities:  

Mesh:

Year:  2011        PMID: 22021662      PMCID: PMC3283156          DOI: 10.1093/schbul/sbr139

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  14 in total

1.  Young people at risk of psychosis: a user-led exploration of interpersonal relationships and communication of psychological difficulties.

Authors:  Rory Byrne; Anthony P Morrison
Journal:  Early Interv Psychiatry       Date:  2010-05       Impact factor: 2.732

2.  Potential stigma associated with inclusion of the psychosis risk syndrome in the DSM-V: an empirical question.

Authors:  Lawrence H Yang; Ahtoy J Wonpat-Borja; Mark G Opler; Cheryl M Corcoran
Journal:  Schizophr Res       Date:  2010-04-18       Impact factor: 4.939

3.  Recruitment and treatment practices for help-seeking "prodromal" patients.

Authors:  Thomas H McGlashan; Jean Addington; Tyrone Cannon; Markus Heinimaa; Patrick McGorry; Mary O'Brien; David Penn; Diana Perkins; Raimo K R Salokangas; Barbara Walsh; Scott W Woods; Alison Yung
Journal:  Schizophr Bull       Date:  2007-05-04       Impact factor: 9.306

4.  Prodromal interventions for schizophrenia vulnerability: the risks of being "at risk".

Authors:  Cheryl Corcoran; Dolores Malaspina; Laura Hercher
Journal:  Schizophr Res       Date:  2005-03-01       Impact factor: 4.939

5.  Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk?

Authors:  Alison R Yung; Hok Pan Yuen; Gregor Berger; Shona Francey; Te-Chieh Hung; Barnaby Nelson; Lisa Phillips; Patrick McGorry
Journal:  Schizophr Bull       Date:  2007-04-02       Impact factor: 9.306

6.  Probably at-risk, but certainly ill--advocating the introduction of a psychosis spectrum disorder in DSM-V.

Authors:  Stephan Ruhrmann; Frauke Schultze-Lutter; Joachim Klosterkötter
Journal:  Schizophr Res       Date:  2010-04-18       Impact factor: 4.939

7.  "Being in a funk": teens' efforts to understand their depressive experiences.

Authors:  Jennifer P Wisdom; Carla A Green
Journal:  Qual Health Res       Date:  2004-11

8.  Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study.

Authors:  Scott W Woods; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Robert Heinssen; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Thomas H McGlashan
Journal:  Schizophr Bull       Date:  2009-04-21       Impact factor: 9.306

9.  The "close-in" or ultra high-risk model: a safe and effective strategy for research and clinical intervention in prepsychotic mental disorder.

Authors:  Patrick D McGorry; Alison R Yung; Lisa J Phillips
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

10.  Anticipating DSM-V: should psychosis risk become a diagnostic class?

Authors:  William T Carpenter
Journal:  Schizophr Bull       Date:  2009-07-24       Impact factor: 9.306

View more
  13 in total

1.  Clinical and demographic correlates of stigma in first-episode psychosis: the impact of duration of untreated psychosis.

Authors:  K T Mueser; N R DeTore; M A Kredlow; M L Bourgeois; D L Penn; K Hintz
Journal:  Acta Psychiatr Scand       Date:  2019-10-11       Impact factor: 6.392

Review 2.  Chances and risks of predicting psychosis.

Authors:  Stephan Ruhrmann; Joachim Klosterkötter; Mitja Bodatsch; Alexandra Nikolaides; Dominika Julkowski; Desire Hilboll; Frauke Schultz-Lutter
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-08-30       Impact factor: 5.270

Review 3.  Mental Health Services Research Targeting the Clinical High-Risk State for Psychosis: Lessons, Future Directions and Integration with Patient Perspectives.

Authors:  Sarah V McIlwaine; Jai Shah
Journal:  Curr Psychiatry Rep       Date:  2021-02-03       Impact factor: 5.285

4.  Emotional and stigma-related experiences relative to being told one is at risk for psychosis.

Authors:  Kristen A Woodberry; Kate S Powers; Caitlin Bryant; Donna Downing; Mary B Verdi; Katherine M Elacqua; Audrey R L Reuman; Leda Kennedy; Daniel I Shapiro; Michelle L West; Debbie Huang; Francesca M Crump; Margaux M Grivel; Drew Blasco; Shaynna N Herrera; Cheryl M Corcoran; Larry J Seidman; Bruce G Link; William R McFarlane; Lawrence H Yang
Journal:  Schizophr Res       Date:  2021-09-28       Impact factor: 4.662

5.  The subjective experience of youths at clinically high risk of psychosis: a qualitative study.

Authors:  Shelly Ben-David; Michael L Birnbaum; Mara E Eilenberg; Jordan E DeVylder; Kelly E Gill; Jessica Schienle; Neyra Azimov; Ellen P Lukens; Larry Davidson; Cheryl M Corcoran
Journal:  Psychiatr Serv       Date:  2014-11-17       Impact factor: 3.084

6.  Counterpoint. Early intervention for psychosis risk syndromes: Minimizing risk and maximizing benefit.

Authors:  Scott W Woods; Carrie E Bearden; Fred W Sabb; William S Stone; John Torous; Barbara A Cornblatt; Diana O Perkins; Kristin S Cadenhead; Jean Addington; Albert R Powers; Daniel H Mathalon; Monica E Calkins; Daniel H Wolf; Cheryl M Corcoran; Leslie E Horton; Vijay A Mittal; Jason Schiffman; Lauren M Ellman; Gregory P Strauss; Daniel Mamah; Jimmy Choi; Godfrey D Pearlson; Jai L Shah; Paolo Fusar-Poli; Celso Arango; Jesus Perez; Nikolaos Koutsouleris; Jijun Wang; Jun Soo Kwon; Barbara C Walsh; Thomas H McGlashan; Steven E Hyman; Raquel E Gur; Tyrone D Cannon; John M Kane; Alan Anticevic
Journal:  Schizophr Res       Date:  2020-05-10       Impact factor: 4.662

7.  The role of fear in mental health service users' experiences: a qualitative exploration.

Authors:  Angela Sweeney; Steve Gillard; Til Wykes; Diana Rose
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-02-22       Impact factor: 4.328

8.  A qualitative phenomenological analysis of the subjective experience and understanding of the at risk mental state.

Authors:  Benjamin Brew; Ciaran Shannon; Lesley Storey; Adrian Boyd; Ciaran Mulholland
Journal:  Int J Qual Stud Health Well-being       Date:  2017-12

9.  Using Online Screening in the General Population to Detect Participants at Clinical High-Risk for Psychosis.

Authors:  Mhairi McDonald; Eleni Christoforidou; Nicola Van Rijsbergen; Ruchika Gajwani; Joachim Gross; Andrew I Gumley; Stephen M Lawrie; Matthias Schwannauer; Frauke Schultze-Lutter; Peter J Uhlhaas
Journal:  Schizophr Bull       Date:  2019-04-25       Impact factor: 9.306

10.  A qualitative study on identity in individuals at clinical high risk for psychosis: " … Why does it have to be one thing?".

Authors:  Cansu Sarac; Joseph S DeLuca; Zarina R Bilgrami; Shaynna N Herrera; Jonathan J Myers; Matthew F Dobbs; Shalaila S Haas; Therese L Todd; Agrima Srivastava; Rachel Jespersen; Riaz B Shaik; Yulia Landa; Larry Davidson; Anthony J Pavlo; Cheryl M Corcoran
Journal:  Psychiatr Rehabil J       Date:  2021-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.